We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
+52.74%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$84M
AUM Growth
+$19.4M
Cap. Flow
-$3.93M
Cap. Flow %
-4.68%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$2.51M
2
DYN icon
Dyne Therapeutics
DYN
+$1.42M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$31.3M 37.26%
3,931,818
– –
DYN icon
2
Dyne Therapeutics
DYN
$4.24B
$27.6M 32.85%
2,074,787
-145,247
-7% -$1.42M
LIAN
3
DELISTED
LianBio American Depositary Shares
LIAN
$10.2M 12.14%
2,282,084
– –
ALLO icon
4
Allogene Therapeutics
ALLO
$604M
$5.77M 6.87%
1,798,163
– –
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$5.23M 6.23%
2,207,772
– –
KRON
6
DELISTED
Kronos Bio
KRON
$3.46M 4.12%
2,765,314
– –
IMA
7
ImageneBio Inc
IMA
$63.2M
$444K 0.53%
18,766
– –
PRAX icon
8
Praxis Precision Medicines
PRAX
$8.8B
– –
-97,978
Closed -$2.51M

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Vida Ventures Advisors held 8 positions worth $84M, up 30% from $64.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors withdrew a net $3.93M in Q4 2023, closing 1 position and reducing 1 holding. Its most notable exit was Praxis Precision Medicines, an estimated $2.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's biggest Q4 2023 reduction was Dyne Therapeutics, cutting an estimated $1.42M.
  • Vida Ventures Advisors fully exited Praxis Precision Medicines in Q4 2023, selling an estimated $2.51M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $84M portfolio in Q4 2023.
  • Vida Ventures Advisors opened 0 new positions and closed 1 in Q4 2023.
  • Vida Ventures Advisors's portfolio value rose 30% quarter-over-quarter to $84M.

Based on Vida Ventures Advisors's 13F filing for Q4 2023, filed 5 Jan 2024.